Blog
What to Know About UniFirst Stock as One Fund Boosts Bet to $89 Million
On February 17, 2026, Engine Capital Management disclosed a significant buy of UniFirst (NYSE:UNF), acquiring 397,772 shares in an estimated $67.13 million trade based on quarterly average pricing.
Warren Buffett Weighed in on Social Security Some Years Ago -- and His Thoughts Might Surprise You
When Warren Buffett speaks, lots of smart people listen. Until recently, he helmed Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB), and over the 60 years when he was in charge, the S&P 500 index of 500
This Billionaire Just Sold Nvidia and AMD Shares to Buy These AI Stocks
Billionaire investor David Tepper of Appaloosa Management was busy making moves to his portfolio in Q4. One of the more interesting themes to emerge was that Tepper trimmed his stakes in artificial
Is Medical Properties Trust Stock Going to $0?
From a high-level view, Medical Properties Trust (NYSE: MPT) has an attractive focus. The real estate investment trust (REIT) owns vital medical facilities, like hospitals. However, the REIT ran
Why Eli Lilly Stock Just Popped
Eli Lilly (NYSE: LLY) stock, maker of the Mounjaro and Zepbound GLP-1 weight loss drugs, enjoyed a modest bounce on Monday, rising 3.6% through 10:30 a.m. ET on some good news for Lilly... and some
Where Will Broadcom (AVGO) Be in 5 Years?
Broadcom's (NASDAQ: AVGO) stock surged more than 600% over the past five years. The tech giant attracted a stampede of bulls as its chip sales surged and it expanded with bold acquisitions. But will
Crypto Market Sell-Off: 1 High-Conviction Cryptocurrency to Buy and 1 to Avoid
The same lessons keep repeating themselves. Investors are being reminded of just how volatile the digital asset ecosystem can be. The market for cryptocurrencies reached a peak valuation of around
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer
On February 17, 2026, Commodore Capital disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold all 2,338,287 shares of Agios Pharmaceuticals (NASDAQ:AGIO) in the fourth
VEA vs. SPDW: Which International ETF Is the Best Choice for Investors?
The Vanguard FTSE Developed Markets ETF (NYSEMKT:VEA) and the SPDR Portfolio Developed World ex-US ETF (NYSEMKT:SPDW) both aim to track the performance of developed markets outside the United
Better Global ETF Buy: Can Investors Earn More with IEFA or SPGM?
Both the State Street SPDR Portfolio MSCI Global Stock Market ETF (NYSEMKT:SPGM) and the iShares Core MSCI EAFE ETF (NYSEMKT:IEFA) aim to provide diversified international equity exposure, but their
IEMG vs. VXUS: Which International ETF Is the Better Buy Right Now?
The Vanguard Total International Stock ETF (NASDAQ:VXUS) and the iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) both aim to provide diversified international equity exposure, but their
Better Buy: How Small-Cap ETFs ISCG and IJT Compare on Fees, Risk, and Income
The iShares S&P Small-Cap 600 Growth ETF (NASDAQ:IJT) and the iShares Morningstar Small-Cap Growth ETF (NYSEMKT:ISCG) both target growth-oriented small-cap U.S. stocks, but they differ in cost
Small-Cap Showdown: How Vanguard's VB Compares to Schwab's SCHA on Fees, Risk, and Diversification
This comparison looks at two of the most popular small-cap index ETFs, each offering broad exposure to U.S. smaller companies.
The Schwab U.S. Small-Cap ETF (NYSEMKT:SCHA) and the Vanguard
Why Novo Nordisk Stock Just Crashed
Novo Nordisk (NYSE: NVO) is taking it on the chin this morning, after revealing the latest clinical trial results for weight loss using its CagriSema drug (a 50-50 mix of amylin analog cagrilintide
Disney's 2026 Film Slate Could Ignite a Powerful Comeback
The Walt Disney Company (NYSE: DIS) may be entering a pivotal year. With Avengers: Doomsday, Toy Story 5, and Moana lined up, 2026 could deliver multiple billion-dollar films. If the slate performs
Eli Lilly: The Weight‑Loss and Diabetes Powerhouse I'd Hold Through Any Market Crash
Some analysts are worried that the artificial intelligence (AI) bubble will burst soon, causing a market crash. Whether or not there's something to these fears, it's a good idea for investors to buy
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake
On February 17, 2026, Commodore Capital disclosed in an SEC filing that it sold out its entire 3,200,000-share position in Viridian Therapeutics (NASDAQ:VRDN), an estimated $69.06 million
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million
Commodore Capital disclosed a buy of 400,161 shares of Spyre Therapeutics (NASDAQ:SYRE), an estimated $10.46 million trade based on quarterly average pricing, per a February 17, 2026, SEC filing.
2 Unstoppable Growth Stocks to Buy Right Now for $1,000
Earnings season is in full swing. So far, Meta Platforms (NASDAQ: META) and Taiwan Semiconductor Manufacturing (NYSE: TSM) have stood out from the pack for their strong performance.
The common
This 4.9%-Yield Oil Pipeline Stock Is up 18% in 2026 -- and Still Looks Cheap
Midstream operator OneOK (NYSE: OKE) operates like a toll booth for the energy industry. Through its 60,000 miles of pipelines, it delivers crude oil, carbon dioxide, natural gas, and natural gas
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50%
Commodore Capital reduced its stake in Centessa Pharmaceuticals (NASDAQ:CNTA) by 1,850,000 shares in the fourth quarter, according to a February 17, 2026, SEC filing. The estimated transaction
3 High-Yield Energy Stocks to Buy in February
Reliable power is the lifeblood of modern society. All you need to do is live through one blackout, and you know just how quickly the world comes to a screeching halt without energy. That is why all
Stepan (SCL) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, February 23, 2026 at 9 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%
Commodore Capital reported a sale of 850,000 shares of Nuvalent (NASDAQ:NUVL) in its latest SEC filing dated February 17, 2026, with the estimated transaction value at $83.81 million based on
Here's Why I Wouldn't Touch Tilray With a 10‑Foot Pole
Tilray Brands (NASDAQ: TLRY) is focused on expanding its reach. The marijuana company has now branched out to include CBD products and alcohol, and has started to call itself "a global lifestyle and